MX2016006788A - Composiciones antibacterianas. - Google Patents
Composiciones antibacterianas.Info
- Publication number
- MX2016006788A MX2016006788A MX2016006788A MX2016006788A MX2016006788A MX 2016006788 A MX2016006788 A MX 2016006788A MX 2016006788 A MX2016006788 A MX 2016006788A MX 2016006788 A MX2016006788 A MX 2016006788A MX 2016006788 A MX2016006788 A MX 2016006788A
- Authority
- MX
- Mexico
- Prior art keywords
- antibacterial compositions
- pharmaceutically acceptable
- acceptable derivative
- ceftibuten
- cefpodoxime
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3704MU2013 IN2013MU03704A (enExample) | 2013-11-26 | 2014-11-26 | |
| PCT/IB2014/066351 WO2015079389A1 (en) | 2013-11-26 | 2014-11-26 | Antibacterial compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016006788A true MX2016006788A (es) | 2016-09-07 |
Family
ID=52347362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016006788A MX2016006788A (es) | 2013-11-26 | 2014-11-26 | Composiciones antibacterianas. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20160296502A1 (enExample) |
| EP (1) | EP3074014A1 (enExample) |
| JP (1) | JP6525999B2 (enExample) |
| KR (1) | KR20160090311A (enExample) |
| CN (1) | CN105792827B (enExample) |
| BR (1) | BR112016012053A2 (enExample) |
| CA (1) | CA2931070A1 (enExample) |
| IN (1) | IN2013MU03704A (enExample) |
| MX (1) | MX2016006788A (enExample) |
| WO (1) | WO2015079389A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109310682A (zh) * | 2016-06-17 | 2019-02-05 | 沃克哈特有限公司 | 抗菌组合物 |
| AU2017295866A1 (en) * | 2016-07-14 | 2019-01-17 | Achaogen, Inc. | Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections |
| KR102354697B1 (ko) * | 2017-03-02 | 2022-01-21 | 욱크하르트 리미티드 | 항박테리아 화합물로서의 헤테로고리 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8796257B2 (en) * | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| HUE046893T2 (hu) * | 2012-05-30 | 2020-04-28 | Meiji Seika Pharma Co Ltd | Új ß-laktamáz inhibitor és eljárás elõállítására |
| ES2672100T3 (es) * | 2012-08-25 | 2018-06-12 | Wockhardt Limited | Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona y su uso en el tratamiento de infecciones bacterianas |
-
2014
- 2014-11-26 CN CN201480064828.1A patent/CN105792827B/zh not_active Expired - Fee Related
- 2014-11-26 CA CA2931070A patent/CA2931070A1/en not_active Abandoned
- 2014-11-26 US US15/036,517 patent/US20160296502A1/en not_active Abandoned
- 2014-11-26 IN IN3704MU2013 patent/IN2013MU03704A/en unknown
- 2014-11-26 JP JP2016533130A patent/JP6525999B2/ja not_active Expired - Fee Related
- 2014-11-26 WO PCT/IB2014/066351 patent/WO2015079389A1/en not_active Ceased
- 2014-11-26 BR BR112016012053A patent/BR112016012053A2/pt not_active Application Discontinuation
- 2014-11-26 MX MX2016006788A patent/MX2016006788A/es unknown
- 2014-11-26 KR KR1020167015290A patent/KR20160090311A/ko not_active Withdrawn
- 2014-11-26 EP EP14827266.9A patent/EP3074014A1/en not_active Withdrawn
-
2018
- 2018-05-01 US US15/968,174 patent/US20180243274A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3074014A1 (en) | 2016-10-05 |
| IN2013MU03704A (enExample) | 2015-07-31 |
| CA2931070A1 (en) | 2015-06-04 |
| KR20160090311A (ko) | 2016-07-29 |
| WO2015079389A1 (en) | 2015-06-04 |
| BR112016012053A2 (pt) | 2017-08-08 |
| US20180243274A1 (en) | 2018-08-30 |
| CN105792827B (zh) | 2020-09-08 |
| JP6525999B2 (ja) | 2019-06-05 |
| CN105792827A (zh) | 2016-07-20 |
| US20160296502A1 (en) | 2016-10-13 |
| JP2016537386A (ja) | 2016-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3847168B8 (en) | New anthelmintic compounds | |
| MX2016011992A (es) | Derivados de piperidina-diona. | |
| NZ739676A (en) | Heteroaryl compounds as irak inhibitors and uses thereof | |
| PH12016501813B1 (en) | 1,3-benzodioxole derivative | |
| GEP20186933B (en) | Substituted dihydroisoquinoline compounds | |
| PH12018500591A1 (en) | Heterocyclic compounds and uses thereof | |
| TW201613911A (en) | Heterocyclic compounds and uses thereof | |
| PH12018500061A1 (en) | Oxysterols and methods of use thereof | |
| EP4643945A8 (en) | Neuroactive steroids and methods of use thereof | |
| WO2014144545A3 (en) | Substituted benzoxazoles and methods of use thereof | |
| MX2017014035A (es) | Formas solidas novedosas. | |
| HK1248069A1 (zh) | 去乙酰氧基微管溶素h及其类似物 | |
| MX2016013431A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MY162886A (en) | Novel tetrahydropyridopyrimidine compound or salt thereof | |
| MX2015015562A (es) | Dihidropiridinona como inhibidores de monoacilglicerol aciltransferasa 2. | |
| MX2018001517A (es) | Derivados sustituidos de guanidina. | |
| MX363530B (es) | Compuesto de benzoxaborol tricíclico, método de preparación y uso del mismo. | |
| MA39877A (fr) | Formes solides d'un composé pharmaceutiquement actif | |
| IN2013MU03704A (enExample) | ||
| IN2014MU00859A (enExample) | ||
| MX2016005160A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MX2016013428A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MX2016005539A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| IN2013MU03309A (enExample) | ||
| IN2013MU03421A (enExample) |